NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-166-1993-0-US-02 cAMP INDUCIBLE PROMOTERS AND METHODS OF USE THEREOF US FWC 08/423,670 Abandoned
NCI E-093-1990-0-US-03 ANTIVIRAL COMPOSITION US FWC 08/424,558 5599839 Expired PDF
NCI E-002-1993-0-US-02 COLON MUCOSA GENE HAVING DOWN REGULATED EXPRESSION IN COLON ADENOMAS AND ADENOCARCINOMAS US FWC 08/424,567 5569755 Abandoned PDF
NCI E-093-1993-0-US-02 NOVEL IMMUNOTHERAPEUTIC METHODS AND VACCINES US FWC 08/424,573 Abandoned
NIMH E-012-1991-4-US-01 THYMIC TOLERANCE IN PRIMATES US CIP 08/422,100 Abandoned
NIDA E-172-1993-4-US-02 Mu-subtype Opioid Receptor US CON 08/430,286 6225080 Expired PDF
NIDDK E-003-1995-0-US-01 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION US ORD 08/420,013 5686614 Expired PDF
NEI E-043-1989-1-US-02 METHODS OF TREATING OR PREVENTING AUTOIMMUNE UVEORETINITIS IN MAMMALS US CON 08/419,505 5961977 Abandoned PDF
NCI E-196-1992-4-US-01 Use of Nitric Oxide-Releasing Agents to Treat Impotency US CIP 08/419,044 5910316 Abandoned PDF
NCI E-196-1992-5-US-01 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS US CIP 08/419,424 5691423 Abandoned PDF
NCI E-047-1994-0-EP-15 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS EP National Stage 95916319.7 Expired
NCI E-134-1994-0-GB-07 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE GB EP 95916141.5 Abandoned
NCI E-134-1994-0-EP-06 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE EP National Stage 95916141.5 Abandoned
NCI E-134-1994-0-IT-12 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE IT EP 95916141.5 Abandoned
NCI E-134-1994-0-FR-09 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE FR EP 95916141.5 Abandoned
NCI E-134-1994-0-DE-05 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE DE EP 95916141.5 Abandoned
NCI E-134-1994-0-CH-11 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE CH EP 95916141.5 Abandoned
NCI E-134-1994-0-BE-10 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE BE EP 95916141.5 Abandoned
NCI E-134-1994-0-AU-03 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE AU National Stage 22748/95 Abandoned
NINDS E-153-1991-1-US-03 DEFECTIVE,INTERFERING HIV PARTICLES US FWC 08/418,848 5847096 Abandoned PDF
NCI E-134-1994-0-PCT-02 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE PCT PCT PCT/US95/03935 Expired
CC E-223-1993-0-PCT-02 No_Patent_Title PCT PCT PCT/US95/004034 Abandoned
NCI E-136-1992-0-CA-04 TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES CA National Stage 2146668 Abandoned
NCI E-134-1994-0-JP-08 HEPATITIS C VIRUS CORE PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES AND DIAGNOSIS OF HCV EXPOSURE JP National Stage 7-526371 Abandoned
NCI E-047-1994-0-CA-14 CIRCULARLY PERMUTED LIGANDS AND CIRCULARLY PERMUTED CHIMERIC MOLECULES CA National Stage 2187283 Expired
NCI E-047-1994-0-ES-04 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS ES EP 95916319.7 Expired
NCI E-047-1994-0-CH-03 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS CH EP 95916319.7 Expired
NCI E-047-1994-0-AT-11 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS AT EP 95916319.7 Expired
NCI E-047-1994-0-BE-13 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS BE EP 95916319.7 Expired
NCI E-047-1994-0-NL-09 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS NL EP 95916319.7 Abandoned
NCI E-047-1994-0-MC-08 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS MC EP 95916319.7 Abandoned
NCI E-047-1994-0-LU-07 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS LU EP 95916319.7 Abandoned
NCI E-047-1994-0-LI-18 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS LI EP 95916319.7 Expired
NCI E-047-1994-0-GB-05 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS GB EP 95916319.7 Expired
NCI E-047-1994-0-IT-06 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS IT EP 95916319.7 Expired
NCI E-047-1994-0-IE-17 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS IE EP 95916319.7 Abandoned
NCI E-047-1994-0-DE-10 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS DE EP 95916319.7 Abandoned
NCI E-047-1994-0-FR-16 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS FR EP 95916319.7 Expired
NCI E-047-1994-0-AU-12 PROTEINS COMPRISING CIRCULARLY PERMUTED LIGANDS AU National Stage 22857/95 Expired
NCI E-196-1992-0-US-02 POLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMA- CEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF TREATING.... US DIV 08/417,913 5718892 Abandoned PDF
NCI E-196-1992-0-US-03 POLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMA- CEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF TREATING... US DIV 08/417,917 5676963 Abandoned PDF
NCI E-047-1994-0-PCT-02 CIRCULARLY PERMUTED LIGANDS AND CIRCULARLY PERMUTED CHIMERIC MOLECULES PCT PCT PCT/US1995/004468 Expired
NIMH E-110-1993-0-AU-13 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM AU National Stage 22746/95 Abandoned
NCI E-113-2000-0-US-08 Immunodeficiency Recombinant Poxvirus US CIP 08/417,210 5863542 Expired PDF
NCI E-057-1994-2-US-01 MELANOMA ANTIGENS [Gp100 only] AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US CIP 08/417,174 5844075 Expired PDF
NIMH E-110-1993-0-PCT-02 Antibacterial Therapy with Genotypically Modified Bacteriophage PCT PCT PCT/US95/03930 Expired
NIMH E-110-1993-0-EP-11 ANTIBACTERIAL THERAPY WITH GENOTYPICALLY MODIFIED BACTERIOPHAGE EP National Stage 95916139.9 Abandoned
NIMH E-110-1993-0-CA-14 ANTIBACTERIAL THERAPY WITH GENOTYPICALLY MODIFIED BACTERIOPHAGE CA National Stage 2186962 Abandoned
NIMH E-110-1993-0-JP-15 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM JP National Stage 7-525828 Abandoned
NIMH E-110-1993-0-TW-12 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM TW ORD 84110296 Abandoned